Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
NatWest ADR | NWG | Nov 25, 2024 | 9.99 | +0.91 |
Nauticus Robotics | KITT | Nov 25, 2024 | 0.89 | -15.79 |
Nautilus Biotechnology | NAUT | Nov 25, 2024 | 2.44 | +1.67 |
Navidea Biopharmaceuticals | NAVB | Nov 25, 2024 | 0.00 | 0.00 |
Navient | NAVI | Nov 25, 2024 | 15.57 | +1.30 |
Navigator Holdings | NVGS | Nov 25, 2024 | 15.88 | -2.70 |
Navios Maritime Partners LP Unit | NMM | Nov 25, 2024 | 49.32 | -4.79 |
Navitas Semiconductor | NVTS | Nov 25, 2024 | 2.78 | +14.88 |
Naya Biosciences | NAYA | Nov 25, 2024 | 0.92 | 0.00 |
Nayax | NYAX | Nov 25, 2024 | 29.26 | +1.99 |
NB Bancorp | NBBK | Nov 25, 2024 | 20.45 | -0.78 |
NBT Bancorp | NBTB | Nov 25, 2024 | 50.99 | +1.07 |
Ncino | NCNO | Nov 25, 2024 | 42.20 | +1.88 |
NCR | VYX | Nov 25, 2024 | 14.71 | +1.45 |
NCR Atleos When Issued | NATL | Nov 25, 2024 | 31.16 | -1.11 |
NCS Multistage | NCSM | Nov 25, 2024 | 22.95 | -0.26 |
Nebius Group | NBIS | Nov 25, 2024 | 23.49 | 0.00 |
Nektar Therapeutics | NKTR | Nov 25, 2024 | 1.09 | +3.81 |
Nelnet | NNI | Nov 25, 2024 | 109.57 | +1.52 |
Neogen | NEOG | Nov 25, 2024 | 15.31 | +2.20 |
NeoGenomics | NEO | Nov 25, 2024 | 16.93 | +3.29 |
Neonode | NEON | Nov 25, 2024 | 8.34 | +2.21 |
NeoVolta | NEOV | Nov 25, 2024 | 5.57 | -3.97 |
Nephros | NEPH | Nov 25, 2024 | 1.54 | +1.99 |
NerdWallet A | NRDS | Nov 25, 2024 | 14.24 | +3.56 |
Nerdy A | NRDY | Nov 25, 2024 | 1.39 | -0.71 |
Net Lease Office Properties When Issued | NLOP | Nov 25, 2024 | 31.57 | +1.51 |
Net Power A | NPWR | Nov 25, 2024 | 13.29 | +5.14 |
NetApp | NTAP | Nov 25, 2024 | 126.18 | +3.14 |
Netcapital | NCPL | Nov 25, 2024 | 2.06 | +16.38 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.